Skip to main content
Log in

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Three 5-HT agonists produced a dose-related fall in open/total arm entry ratio in the elevated X-maze model of anxiety at doses which did not affect total entries. The relative potency, 8-hydroxy-2-(di-n-propylamino)tetra lin (8-OH-DPAT)≫5-methoxy-N,N-dimethyltryptamine (5-MeODMT)>=5-methoxy-3(tetrahydropyridin-4-yl)1H-indole (RU 24969), was unrelated to the occurrence of wet dog shakes and suggests that 5-HT1 rather than 5-HT2 receptors may be involved. However, the 5-HT2 receptor antagonists ritanserin, ketanserin and seganserin caused an anxiolytic-like increase in entry ratio, although only ritanserin produced this effect across the dose range tested. +/-Pindolol, an antagonist at 5-HT1 receptors, showed a biphasic dose-response curve with a fall in entry ratio at one high dose. The effect of a submaximal dose of 8-OH-DPAT was prevented by pindolol but not by a similarly anxiolytic dose of ritanserin or diazepam. A higher dose of diazepam caused intense muscle hypotonia in combination with 8-OH-DPAT. Since open/total entry ratio appears to represent choice, rather than suppression or delay, of a response, the effects seen may indicate involvement of 5-HT receptors in anxiety separately from any change in the ability to withhold a response. The precise role of each receptor subtype, however, remains to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arriaga F, Leitas J, Mills FJ, Padua J, Ruiz I, Tropa J, Sousa MP (1984) R55667, an effective non-benzodiazepine anxiolytic. Proc. 14th C.I.N.P. Congr Florence [Abstr] P726

  • Bradley PB, Engel G, Fenuik W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-HT. Neuropharmacology 25:563–576

    Google Scholar 

  • Ceulemans D, Hoppenbrouwers ML, Gelders Y, Reyntjens A (1984) Serotonin blockade or benzodiazepines: What kind of anxiolysis? Proc 14th C.I.N.P. Congr Florence [Abstr] P726

  • Colpaert FC, Meet TF, Niemegeers CJE, Janssen PAJ (1985) Behavioural and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in the rat. Psychopharmacology 86:45–54

    Google Scholar 

  • Dourish CT, Hutson PH, Curzon G (1985) Low doses of the putative serotonin agonist 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology 86:197–204

    Google Scholar 

  • Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist B (1984) Anticonflict effects of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 105:365–368

    Google Scholar 

  • File SE, Johnston AL, Pellow S (1987) Effects of compounds acting at CNS 5-hydroxytryptamine systems on anxiety in the rat. Br J Pharmacol 90:265P

    Google Scholar 

  • Gardner CR (1985) Pharmacological studies of the role of serotonin in animal models of anxiety. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, New York

    Google Scholar 

  • Gardner CR (1986) Recent developments in 5-HT-related pharmacology of animal models of anxiety. Pharmacol Biochem Behav 24:1479–1485

    CAS  PubMed  Google Scholar 

  • Handley SL, Mithani S (1984) Effects of α-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear-motivated’ behaviour. Naunyn-Schmiedeberg's Arch Pharmacol 327:1–5

    Google Scholar 

  • Hjorth S, Carlsson A (1986) Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur J Pharmacol 129:131–138

    Google Scholar 

  • Hutson PH, Dourish CT, Curzon G (1986) Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur J Pharmacol 129:347–352

    Google Scholar 

  • Janssen PAJ (1985) The pharmacology of potent and selective S2-serotonergic antagonists. J Cardiovasc Pharmacol [Suppl 7] 7:S2-S11

    Google Scholar 

  • Johnston AL, File SE (1986) 5-HT and anxiety: promises and pitfalls. Pharmacol Biochem Behav 24:1467–1470

    Google Scholar 

  • Leysen JE, Awouters F, Kennis L, Laduron PM, Vaneberk PAJ (1981) Receptor profile of R41468 (ketanserin) a novel antagonist at 5-HT2 receptors. Life Sci 28:1015–1022

    Google Scholar 

  • Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, Laduron PM (1985) Receptor binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27:600–611

    Google Scholar 

  • Middlemiss DN, Blakeborough L, Leather SR (1977) Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor. Nature 267:289

    Google Scholar 

  • Montgomery KC (1955) The relation between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol 48:254–260

    Google Scholar 

  • Nahorski SR, Wilcocks AL (1983) Interactions of β-adrenoceptor antagonists with 5-hydroxytryptamine receptor subtypes in rat cerebral cortex. Br J Pharmacol 78:107P

    Google Scholar 

  • Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]-5-Hydroxytryptamine binding sites by the neuroleptic spiperone in the rat brain. J Neurochem 36:220

    Google Scholar 

  • Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze. A novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525–529

    Article  CAS  PubMed  Google Scholar 

  • Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167

    Google Scholar 

  • Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: Differential binding of [3H]-5-HT, [3H]-LSD and [3H]-spiroperidol. Mol Pharmacol 16:687–699

    CAS  PubMed  Google Scholar 

  • Richardson BP, Engel G (1986) The pharmacology and function of 5-HT3 receptors. Trends Neurol Sci 9:424

    Google Scholar 

  • Shephard RA, Buxton DA, Broadhurst PL (1982) Drug interactions do not support reduction of serotonin turnover as a mechanism of action of benzodiazepines. Neuropharmacology 21:1027

    Google Scholar 

  • Soubrié P (1986) Neurones sérotoninergiques et comportement. J Pharmacol 17:107–112

    Google Scholar 

  • Thiébot MH (1986) Are serotonergic neurones involved in the control of anxiety and in the anxiolytic activity of benzodiazepines? Pharmacol Biochem Behav 24:1471–1477

    Google Scholar 

  • Tricklebank MD (1985) The behavioural response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. TIPS 6:403–407

    Google Scholar 

  • Tricklebank MD, Forler C, Fozard JR (1985) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271–282

    Google Scholar 

  • Tricklebank MD, Middlemiss DN, Neill J (1986) Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969 in the rat. Neuropharmacology 25:877–886

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Critchley, M.A.E., Handley, S.L. Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology 93, 502–506 (1987). https://doi.org/10.1007/BF00207243

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00207243

Key words

Navigation